Vaping and Smoking Withdrawal Project
State University of New York at Buffalo · with Roswell Park Cancer Institute, National Institute on Drug Abuse (NIDA) · NCT05772845
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 370
- US sites recruiting
- 1
- Study start
- February 14, 2023
- Record last updated
- March 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed research, which will systematically and comprehensively characterize the withdrawal among daily vapers compared to daily smokers of combustible cigarettes, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence/abuse liability and contributing to the development of therapies for tobacco/nicotine use, the leading preventable cause of death in the US.
Being studied: Acute (24-hour) abstinence; Ad libitum smoking/vaping
Conditions: Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 6+ months of daily/near-daily nicotine vaping and/or cigarette smoking (to yield 160 vapers, 160 smokers, 50 dual users)
- 200+ ng/mL cotinine on a commercially-available quick screen
Current Exclusion Criteria
- intention to quit daily/near-daily vaping/smoking in the next month
- current (2+ days out of the past 7) use of pipe tobacco, hookah/shisha, smokeless tobacco, dissolvable tobacco, nicotine pouches. For vaping group only, current (2+ days out of past 7) use of cigars, cigarillos, or filtered cigars that are filled with tobacco or a mix of tobacco and marijuana
- current use of any smoking cessation medication
- current severe substance dependence other than tobacco/nicotine (including cannabis; NIDA Modified ASSIST of 27+)
- current (past 2 weeks) suicidal ideation with intent and/or plan
- current antipsychotic medications or lifetime history of schizophrenia or bipolar disorder
- pregnancy (intake urine screen)
Original Exclusion Criteria that have been modified or eliminated:
- >1 use in past month of tobacco/nicotine products other than ENDS and combustible cigarettes (modified 5/19/25 - see current exclusion criteria)
- alcohol: AUDIT > 15 for males and >13 for females (eliminated 7/25/23)
- current major depression (PHQ-9>11) (eliminated 7/25/23)
- suicide risk (answer to question #9 on PHQ-9 is anything other than "Not at all") (modified 11/17/23 - see current exclusion criteria)
Recruiting US locations
University at Buffalo
Buffalo, NY 14260
Site contact: Larry Hawk, PhD · 7166450192 · lhawk@buffalo.edu
Study contacts (from the official record)
- Larry Hawk, PhD · 716-645-0192 · lhawk@buffalo.edu
Similar studies in New York
All smoking & vaping studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Roswell Park Cancer Institute
- Location
- Buffalo, NY
- Eligibility basics
- Ages 21+
- RecruitingHealthy volunteers
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Viome
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Brooklyn, NY + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- Rochester, NY + 16 other US sites
- Eligibility basics
- Ages 18–75